MedTrace Logo

Adjunct VR Pain Management in Acute Brain Injury

NCT04356963 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-04-24

Study results available
· View outcomes & findings →

Summary

Severe and refractory pain after acute injury is a known-risk factor for chronic opioid use disorder. In this study, the investigators will use Virtual Reality (VR) immersion as a non-pharmacological adjunct to treat pain associated with acute traumatic injuries, including traumatic brain injury. The investigators hypothesize that VR therapy will decrease pain and reduce opioid use in patients with acute traumatic injuries, including TBI.

Conditions

Interventions

BEHAVIORAL

Virtual Reality Session (VR Blu)

20-30 minute session of virtual reality immersive content.

BEHAVIORAL

Tablet-based Session (Tablet Blu)

20-30 minute session of tablet-based content that mimics the content from virtual reality sessions.

BEHAVIORAL

Use of Virtual Reality Head Mounted Display without Content (VR Blank)

20-30 minutes session using head mounted display to reduce light and sound.

Sponsors & Collaborators

  • National Center for Advancing Translational Sciences (NCATS)

    collaborator NIH

  • University of Maryland, Baltimore

    lead OTHER

Principal Investigators

  • Nicholas A Morris, M.D. · University of Maryland, Baltimore

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-05
Primary Completion
2022-01-07
Completion
2022-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04356963 on ClinicalTrials.gov